ATHN 2: Factor Switching Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ellis J Neufeld, MD, PhD
St. Jude Children's Research Hospital
Principal Investigator - Janna Journeycake, MD
Oklahoma Center for Bleeding and Clotting Disorders
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Diego (ucsd)
San Diego, California, United States
- University of Colorado Denver Hemophilia and Thrombosis Center
Aurora, Colorado, United States
- Yale Hemophilia Treatment Center
New Haven, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- St. Joseph'S Children'S Hospital
Tampa, Florida, United States
- Children'S Healthcare of Atlanta/emory
Atlanta, Georgia, United States
- Bleeding and Clotting Disorders Institute
Peoria, Illinois, United States
- Indiana Hemophilia and Thrombosis Center (ihtc)
Indianapolis, Indiana, United States
- Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana, United States
- Maine Hemophilia and Thrombosis Center
Scarborough, Maine, United States
- Johns Hopkins University Medical Center
Baltimore, Maryland, United States
- Boston Hemophilia Center at Children'S Hospital of Boston
Boston, Massachusetts, United States
- University of Michigan Hemophilia and Coagulation Disorders Program
Ann Arbor, Michigan, United States
- Michigan State University Center for Bleeding and Clotting Disorders
East Lansing, Michigan, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center
Lebanon, New Hampshire, United States
- Weill Cornell Medicine
New York, New York, United States
- Mary M. Gooley Hemophilia Center
Rochester, New York, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia (chop)
Philadelphia, Pennsylvania, United States
- Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- the Hemophilia Center of Western Pennsylvania
Pittsburgh, Pennsylvania, United States
- St Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Utsw Medical Center at Dallas/children'S Medical Center
Dallas, Texas, United States
- Washington Center for Bleeding Disorders Bloodworks Northwest D/b/a Puget Sound Blood Center
Seattle, Washington, United States
- Blood Center of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2015
- Primary completion
- 30 Jun 2020
- Completion
- 30 Jun 2020
- Last update posted
- 9 Dec 2021
- Registered enrollment
- 310
- Registry id
- NCT02546622
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.